The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma

BACKGROUND: The use of chemotherapy regimens with moderate or high risk of febrile neutropenia (defined as having a FN incidence of 10% or more) and the respective incidence and clinical management of FN in breast cancer and NHL has not been studied in Belgium. The existence of a medical need for G-...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerlier, Laetitia, Lamotte, Mark, Awada, Ahmad, Bosly, André, Bries, Greet, Cocquyt, Véronique, Focan, Christian, Henry, Stéphanie, Lalami, Yassine, Machiels, Jean-Pascal, Mebis, Jeroen, Straetmans, Nicole, Verhoeven, Didier, Somers, Luc
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006392/
https://www.ncbi.nlm.nih.gov/pubmed/21092320
http://dx.doi.org/10.1186/1471-2407-10-642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006392/
https://www.ncbi.nlm.nih.gov/pubmed/21092320
http://dx.doi.org/10.1186/1471-2407-10-642

Ejemplares similares